Virtus Etf Profile

BBP Etf  USD 52.43  0.17  0.33%   
Market Performance
9 of 100
Odds Of Distress
Less than 37
Virtus LifeSci is selling at 52.43 as of the 27th of January 2023; that is 0.33 percent up since the beginning of the trading day. The etf's last reported lowest price was 52.27. Virtus LifeSci has about a 37 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Virtus LifeSci Biotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of December 2022 and ending today, the 27th of January 2023. Click here to learn more.
Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States. More on Virtus LifeSci Biotech

Moving together with Virtus LifeSci

+0.82XBISPDR SP Biotech Aggressive PushPairCorr
+0.68SPYSPDR SP 500 Aggressive PushPairCorr
+0.9BNDVanguard Total Bond Sell-off TrendPairCorr

Virtus LifeSci Etf Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Virtus LifeSci's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Virtus LifeSci or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Macroaxis Advice
The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Virtus LifeSci's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong HoldFairly Valued
IssuerVirtus
Inception Date2014-12-16
BenchmarkLifeSci Biotechnology Products Index
Entity TypeRegulated Investment Company
Asset Under Management18.28 Million
Average Trading Valume1,933.5
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorVirtus ETF Solutions, LLC
AdvisorVirtus ETF Advisers LLC
CustodianThe Bank of New York Mellon Corporation
DistributorETF Distributors LLC
Portfolio ManagerMatthew B. Brown, Seth Kadushin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year End31-Aug
ExchangeNYSE Arca, Inc.
Number of Constituents63.0
Market MakerVirtu Financial
Total Expense0.79
Management Fee0.79
Nav Price46.7
Two Hundred Day Average43.64
Ytd-5.43%
Average Daily Volume In Three Month1.13k
Fifty Two Week Low34.12
As Of Date25th of October 2022
Average Daily Volume Last 10 Day1.15k
Fifty Two Week High50.68
One Month3.91%
Fifty Day Average46.65
Three Month7.74%
Beta In Three Year0.56
Virtus LifeSci Biotech [BBP] is traded in USA and was established 2014-12-16. The fund is classified under Health category within Virtus family. Virtus LifeSci Biotech currently have 15.87 M in assets under management (AUM). , while the total return for the last 3 years was 6.99%.
Check Virtus LifeSci Probability Of Bankruptcy

Geographic Allocation (%)

Top Virtus LifeSci Biotech Etf Constituents

Virtus LifeSci Target Price Odds Analysis

Contingent on a normal probability distribution, the odds of Virtus LifeSci jumping above the current price in 90 days from now is roughly 2.77%. The Virtus LifeSci Biotech probability density function shows the probability of Virtus LifeSci etf to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Virtus LifeSci has a beta of 0.9152 suggesting Virtus LifeSci Biotech market returns are highly reactive to returns on the market. As the market goes up or down, Virtus LifeSci is expected to follow. Additionally, the company has an alpha of 0.0416, implying that it can generate a 0.0416 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 52.43HorizonTargetOdds Above 52.43
97.17%90 days
 52.43 
2.77%
Based on a normal probability distribution, the odds of Virtus LifeSci to move above the current price in 90 days from now is roughly 2.77 (This Virtus LifeSci Biotech probability density function shows the probability of Virtus Etf to fall within a particular range of prices over 90 days) .

Virtus LifeSci Biotech Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Virtus LifeSci market risk premium is the additional return an investor will receive from holding Virtus LifeSci long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Virtus LifeSci. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Virtus LifeSci's alpha and beta are two of the key measurements used to evaluate Virtus LifeSci's performance over the market, the standard measures of volatility play an important role as well.

Virtus LifeSci Against Markets

Picking the right benchmark for Virtus LifeSci etf is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Virtus LifeSci etf price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Virtus LifeSci is critical whether you are bullish or bearish towards Virtus LifeSci Biotech at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Virtus LifeSci without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

Invested in Virtus LifeSci Biotech?

The danger of trading Virtus LifeSci Biotech is mainly related to its market volatility and ETF specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Virtus LifeSci is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Virtus LifeSci. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Virtus LifeSci Biotech is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Virtus LifeSci Biotech information on this page should be used as a complementary analysis to other Virtus LifeSci's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Virtus Etf analysis

When running Virtus LifeSci Biotech price analysis, check to measure Virtus LifeSci's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virtus LifeSci is operating at the current time. Most of Virtus LifeSci's value examination focuses on studying past and present price action to predict the probability of Virtus LifeSci's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Virtus LifeSci's price. Additionally, you may evaluate how the addition of Virtus LifeSci to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Correlations
Find global opportunities by holding instruments from different markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine Virtus LifeSci value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.